These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 23940627)
1. B7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis. Wang L; Zhang Q; Chen W; Shan B; Ding Y; Zhang G; Cao N; Liu L; Zhang Y PLoS One; 2013; 8(8):e70689. PubMed ID: 23940627 [TBL] [Abstract][Full Text] [Related]
2. Expression of B7-H3 in cancer tissue during osteosarcoma progression in nude mice. Yin SJ; Wang WJ; Zhang JY Genet Mol Res; 2015 Nov; 14(4):14253-61. PubMed ID: 26600483 [TBL] [Abstract][Full Text] [Related]
3. Immune Surveillance Plays a Role in Locally Aggressive Giant Cell Lesions of Bone. Al-Sukaini A; Hornicek FJ; Peacock ZS; Kaban LB; Ferrone S; Schwab JH Clin Orthop Relat Res; 2017 Dec; 475(12):3071-3081. PubMed ID: 28725958 [TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma. Wang L; Kang FB; Sun N; Wang J; Chen W; Li D; Shan BE Tumour Biol; 2016 Nov; 37(11):14939-14947. PubMed ID: 27644254 [TBL] [Abstract][Full Text] [Related]
5. B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence. Sun TW; Gao Q; Qiu SJ; Zhou J; Wang XY; Yi Y; Shi JY; Xu YF; Shi YH; Song K; Xiao YS; Fan J Cancer Immunol Immunother; 2012 Nov; 61(11):2171-82. PubMed ID: 22729558 [TBL] [Abstract][Full Text] [Related]
6. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer. Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202 [TBL] [Abstract][Full Text] [Related]
7. Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer. Yim J; Koh J; Kim S; Song SG; Ahn HK; Kim YA; Jeon YK; Chung DH Eur J Cancer; 2020 Jul; 133():74-85. PubMed ID: 32447027 [TBL] [Abstract][Full Text] [Related]
8. B7-H3 and its role in bone cancers. He L; Li Z Pathol Res Pract; 2019 Jun; 215(6):152420. PubMed ID: 31060912 [TBL] [Abstract][Full Text] [Related]
9. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer. Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients. Song QC; Shi ZB; Zhang YT; Ji L; Wang KZ; Duan DP; Dang XQ Oncol Rep; 2014 Mar; 31(3):1263-70. PubMed ID: 24452597 [TBL] [Abstract][Full Text] [Related]
11. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis. Li Y; Zhang J; Han S; Qian Q; Chen Q; Liu L; Zhang Y Oncol Rep; 2017 Aug; 38(2):1043-1050. PubMed ID: 28627681 [TBL] [Abstract][Full Text] [Related]
12. Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity. Cao JW; Lake J; Impastato R; Chow L; Perez L; Chubb L; Kurihara J; Verneris MR; Dow S Cancer Immunol Immunother; 2024 Mar; 73(5):77. PubMed ID: 38554158 [TBL] [Abstract][Full Text] [Related]
13. B7-H3 on breast cancer cell MCF7 inhibits IFN-γ release from tumour-infiltrating T cells. Shao L; Yu Q; Xia R; Zhang J; Gu S; Yu D; Zhuang Z Pathol Res Pract; 2021 Aug; 224():153461. PubMed ID: 34265738 [TBL] [Abstract][Full Text] [Related]
14. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration. Kim GE; Kim NI; Park MH; Lee JS Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic roles of astrocyte elevated gene-1 (AEG-1) in osteosarcoma progression and prognosis. Wang F; Ke ZF; Sun SJ; Chen WF; Yang SC; Li SH; Mao XP; Wang LT Cancer Biol Ther; 2011 Sep; 12(6):539-48. PubMed ID: 21750404 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma. Li Z; Liao Q; Wu Y; Liao M; Hao Y; Zhang S; Song S; Li B; Zhang YD Pathol Oncol Res; 2012 Jul; 18(3):657-61. PubMed ID: 22215309 [TBL] [Abstract][Full Text] [Related]
17. A high-content screen of FDA approved drugs to enhance CAR T cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKCα activation. Lee HW; O'Reilly C; Beckett AN; Currier DG; Chen T; DeRenzo C J Exp Clin Cancer Res; 2024 Apr; 43(1):97. PubMed ID: 38561833 [TBL] [Abstract][Full Text] [Related]
18. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients. Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786 [TBL] [Abstract][Full Text] [Related]
19. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer. Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710 [TBL] [Abstract][Full Text] [Related]
20. Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis. Huang JF; Du WX; Chen JJ J BUON; 2016; 21(5):1279-1286. PubMed ID: 27837634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]